Sera Prognostics Q4 Earnings Call Highlights

Core Insights - The company is focusing on evidence-based practices in medical affairs for 2026, particularly through the PRIME initiative, which aims to identify risks early in the second trimester and standardize treatment pathways to reduce neonatal hospital utilization [1] Financial Performance - For the full year 2025, the company reported revenue of $81,000, a slight increase from $77,000 in 2024, with a net loss of $31.9 million compared to $32.9 million in the previous year [17] - The company ended 2025 with $95.8 million in cash, which is expected to fund operations through 2028 under the current plan [5][18] - Fourth-quarter revenue was $10,000, down from $24,000 in the same quarter of 2024, with operating expenses of $9.0 million, a decrease from $9.4 million year-over-year [16] Clinical and Regulatory Developments - The PRIME study, published in January 2026, demonstrated a 56% reduction in births before 32 weeks and a 32% reduction before 35 weeks, along with a ~20% reduction in NICU admissions, positioning the PreTRM test as a key catalyst for commercialization [7][2] - The company is advancing its regulatory pathway for the PreTRM Global Test in Europe and plans to submit European dossiers for CE marking approval in the coming months [14] Commercial Strategy - The company is expanding its payer and partner programs, moving from pilot initiatives to formal partnerships, with goals to engage 15–17 states by the end of 2026, covering approximately 58%–60% of U.S. births [6][9] - Management emphasized a "region-first" approach to build local market density through payer engagement, provider education, and patient awareness efforts [10] Future Outlook - The company aims for disciplined execution in 2026, focusing on advancing partner programs, expanding real-world data, and supporting clinicians in integrating the PreTRM test into their workflows [20] - Increased engagement with payers and providers is expected following the publication of the PRIME study, which has led to renewed interest from various stakeholders [13][10]